Medical News

RSS

Insurers under fire for denials of care, inadequate coverage

When people talk about revamping the health care system, among the often-mentioned reasons for change are unfair denials of care by insurance companies and medical debt, both of which are in the news today.

24 Nov 2009

OmniComm Systems chosen as Beardsworth's preferred EDC provider

OmniComm Systems, Inc., one of the fastest growing companies in the EDC marketplace, today announced that Beardsworth, a full service contract research organization (CRO) who specializes in difficult therapeutic areas, has selected OmniComm's TrialMaster EDC solution for conducting a Phase II vaccine study.

24 Nov 2009

New Medicare rules on home-oxygen affect patients, businesses

The Wall Street Journal: "New Medicare rules designed to reduce waste and fraud in medical-equipment reimbursements are driving some home-oxygen suppliers out of business and leaving patients scrambling to find new providers." The rules - scheduled to go into effect January 1, apply to people "who rely on Medicare to pay for oxygen services, which relieve the symptoms of conditions such as emphysema and chronic obstructive pulmonary disease."

24 Nov 2009

Groups on both sides of abortion issue revived in Senate reform fight

The Wall Street Journal reports that abortion-rights groups are mobilizing to keep a provision that would toughen abortion restrictions out of a Senate health care reform bill. "Activists hope to flood Washington to rally and lobby on Dec. 2, during the week that Senate floor debate begins." Ads are running to criticize the restrictions and a new coalition — the Coalition to Pass Health Care Reform and Stop Stupak — is being formed, The Journal reports.

24 Nov 2009

Ohr Pharmaceutical to develop OHR/AVR118 for cachexia treatment

Ohr Pharmaceutical Inc. is developing OHR/AVR118 for treatment of cachexia based on technology acquired earlier this year from Advanced Viral Research Corp. OHR/AVR118 has shown excellent therapeutic efficacy and safety in human clinical trials in over 100 patients with applications for cachexia in Cancer and AIDS patients, as well as Rheumatoid Arthritis.

24 Nov 2009

Poll: Women in their 40's will still get mammograms, despite new guidelines

USA Today reports that "[a] vast majority of American women plan to ignore controversial new recommendations about mammograms, a USA TODAY/Gallup Poll shows. The poll also shows that most women sharply overestimate their risk of developing the disease."

24 Nov 2009

Medical Nutrition launches Diff-Stat pre- and probiotic supplement to prevent the onset of AAD and C-diff

Medical Nutrition USA, Inc., a developer and distributor of uniquely engineered, nutrition-medicine products, announced the introduction of Diff-Stat™, a new supplement containing pre- and probiotics to help restore and maintain beneficial bacteria that prevent the onset of antibiotic-associated diarrhea (AAD) and clostridium difficile (C-diff).

24 Nov 2009

Fourth-quarter and fiscal year-end 2009 results announced by IASIS Healthcare

IASIS Healthcare® LLC today announced financial and operating results for the fiscal fourth quarter and year ended September 30, 2009.

24 Nov 2009

CytRx to initiate a multinational Phase 2 clinical trial of its doxorubicin prodrug

CytRx Corporation, a biopharmaceutical company, today announced plans to initiate a multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a treatment for patients with advanced soft tissue sarcomas who have failed surgery and radiation. Soft tissue sarcomas are cancers that are formed in the muscle, fat, fibrous tissue, blood vessels or other supporting tissue of the body.

24 Nov 2009

Fourth-quarter and full year fiscal 2009 results announced by AVANIR Pharmaceuticals

AVANIR Pharmaceuticals, Inc. today reported unaudited financial results for the three and twelve months ended September 30, 2009.

24 Nov 2009

Roche, Spanish Department of Health to collaborate in Medical Genome Project

Roche and the Department of Health of Junta de Andalucía, Spain have signed an agreement for a cooperation in the Medical Genome Project (MGP), a research project created to analyse the genomes of people with rare diseases and identify the defective gene or genes causing the disease and its behaviour.

From Roche Sequencing and Life Science 24 Nov 2009

Innovation Award for GMI presented at the 2009 World Congress on Medical Physics

Gamma Medica-Ideas, Inc., a leading developer of digital molecular imaging systems, announced today that it has been awarded an Innovation Award for its new prototype imaging system that combines the molecular imaging (MI) capability of single-photon nuclear imaging with magnetic resonance imaging (MRI). The award was presented to GMI at the 2009 World Congress on Medical Physics and Biomedical Engineering in Munich, Germany that took place on September 7th, 2009.

24 Nov 2009

Studies demonstrate clinical utility of Given Imaging's PillCam SB capsule endoscopy

Given Imaging Ltd., the global leader in patient-friendly GI diagnostic and monitoring solutions, today announced three new studies that demonstrate the clinical utility of PillCam SB capsule endoscopy in providing physicians with critical information on how they manage and/or diagnose intestinal disorders. These novel studies were carried out in pediatric patients with gastrointestinal symptoms, including children with known or suspected Crohn's disease.

24 Nov 2009

Given Imaging releases RAPID pH review and analysis software for the Bravo pH Monitoring System

Given Imaging Ltd., the global leader in patient-friendly GI diagnostic and monitoring solutions, today unveiled RAPID® pH review and analysis software for the Bravo® pH Monitoring System. This all-new software was designed to streamline pH monitoring workflow through simplified, easy-to-use screen layouts and intuitive software navigation.

24 Nov 2009

Fourth-quarter and year-end fiscal 2009 results announced by Allied Healthcare International

Allied Healthcare International Inc., a leading provider of flexible healthcare staffing services in the United Kingdom, has issued financial results for its fiscal 2009 fourth quarter and year-end.

24 Nov 2009

Orexigen Therapeutics' committee grants an inducement stock option

Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that on November 18, 2009 the Compensation Committee of the Company's Board of Directors granted an inducement stock option to purchase 200,000 shares of common stock to Preston Klassen, M.D., its newly appointed Head of the Global Contrave Program.

24 Nov 2009

ConvaTec launches new web site on Hydrofiber Technology in Canada

ConvaTec, a world-leading provider of innovative medical technologies for community and hospital care, today announced the launch in Canada of a new web site, www.Hydrofiber.ca, demonstrating how the company's proprietary Hydrofiber(R) Technology is transforming wound care.

24 Nov 2009

Fourth-quarter and full year fiscal 2009 results announced by Hillenbrand

Hillenbrand reported net revenues of $153.1 million for the fourth quarter of 2009, which ended Sept. 30, 2009, a $5.7 million (3.6 percent) decline from the same period in fiscal 2008. The company posted net income of $22.6 million, a $3.4 million (17.7 percent) increase from last year.

24 Nov 2009

National certification for interpreters initiated to ensure accurate communication and prevention of medical errors

Patients in the United States with limited English proficiency (LEP) continue to face language barriers that threaten their health and undermine their well-being. But they are one step closer to equitable healthcare with the launch of the first National Certification for Medical Interpreters in October 2009. A culmination of an over 23-year effort, this first-of-its-kind national interpreting standard certifies that those interpreting are tested and competent as "Certified Medical Interpreters" (CMIs).

24 Nov 2009

Shire submits a MAA for velaglucerase alfa in Europe

Shire plc, the global specialty biopharmaceutical company, today announced that it has submitted a MAA to the European Medicines Agency for velaglucerase alfa, the company's enzyme replacement therapy in development for the treatment of Type 1 Gaucher disease.

24 Nov 2009

Medical News

Insurers under fire for denials of care, inadequate coverage

OmniComm Systems chosen as Beardsworth's preferred EDC provider

New Medicare rules on home-oxygen affect patients, businesses

Groups on both sides of abortion issue revived in Senate reform fight

Ohr Pharmaceutical to develop OHR/AVR118 for cachexia treatment

Poll: Women in their 40's will still get mammograms, despite new guidelines

Medical Nutrition launches Diff-Stat pre- and probiotic supplement to prevent the onset of AAD and C-diff

Fourth-quarter and fiscal year-end 2009 results announced by IASIS Healthcare

CytRx to initiate a multinational Phase 2 clinical trial of its doxorubicin prodrug

Fourth-quarter and full year fiscal 2009 results announced by AVANIR Pharmaceuticals

Roche, Spanish Department of Health to collaborate in Medical Genome Project

Innovation Award for GMI presented at the 2009 World Congress on Medical Physics

Studies demonstrate clinical utility of Given Imaging's PillCam SB capsule endoscopy

Given Imaging releases RAPID pH review and analysis software for the Bravo pH Monitoring System

Fourth-quarter and year-end fiscal 2009 results announced by Allied Healthcare International

Orexigen Therapeutics' committee grants an inducement stock option

ConvaTec launches new web site on Hydrofiber Technology in Canada

Fourth-quarter and full year fiscal 2009 results announced by Hillenbrand

National certification for interpreters initiated to ensure accurate communication and prevention of medical errors

Shire submits a MAA for velaglucerase alfa in Europe

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News